Seizure prophylaxis in glioma surgery: a synopsis from the SPRING RCT.
Underpowered SPRING Trial Leaves Levetiracetam Prophylaxis in Glioma Surgery Unresolved — A phase III randomised controlled trial found no evidence of a difference in 12-month seizure risk between prophylactic levetiracetam and no prophylaxis in seizure-naive glioma patients, but the trial enrolled only 94 of its planned 804 participants, rendering any conclusion statistically unreliable.